Trials / Completed
CompletedNCT02308215
Retinal Therapy Guided by 3D OCT Image Analysis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 77 (actual)
- Sponsor
- Michael Abramoff · Academic / Other
- Sex
- All
- Age
- 45 Years – 120 Years
- Healthy volunteers
- Not accepted
Summary
The main purpose is to find a better way to predict the timing of treatments given to patients with Wet Age-related macular degeneration using image analysis.
Detailed description
The study focuses on making better use of advanced three-dimensional imaging and analysis to allow physicians to know when a treatment is being effective and thus not overuse it. The study will examine how 3-D optical coherence tomography and related image analysis can be used to assess changes in the macula and retina of patients' eyes. These changes can reveal how well a person is responding to anti-VEGF treatment and thus help doctors provide proper treatment timing and care.
Conditions
Timeline
- Start date
- 2010-07-01
- Primary completion
- 2018-07-05
- Completion
- 2018-07-05
- First posted
- 2014-12-04
- Last updated
- 2019-08-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02308215. Inclusion in this directory is not an endorsement.